Dynavax Technologies [DVAX] vs Perrigo Company plc [PRGO] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Dynavax Technologies Corporation wins in 11 metrics, Perrigo Company plc wins in 9 metrics, with 0 ties. Dynavax Technologies Corporation appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Dynavax Technologies Corporation | Perrigo Company plc | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 54.60 | 2,818.00 | Dynavax Technologies Corporation |
| Price-to-Book Ratio | 3.41 | 0.55 | Perrigo Company plc |
| Debt-to-Equity Ratio | 54.15 | 131.16 | Dynavax Technologies Corporation |
| PEG Ratio | 0.71 | 0.91 | Dynavax Technologies Corporation |
| EV/EBITDA | 60.37 | 7.26 | Perrigo Company plc |
| Profit Margin (TTM) | -13.13% | -33.51% | Dynavax Technologies Corporation |
| Operating Margin (TTM) | 24.77% | 10.20% | Dynavax Technologies Corporation |
| EBITDA Margin (TTM) | 24.77% | 10.20% | Dynavax Technologies Corporation |
| Return on Equity | -7.14% | -38.66% | Dynavax Technologies Corporation |
| Return on Assets (TTM) | 1.20% | 2.35% | Perrigo Company plc |
| Free Cash Flow (TTM) | $60.16M | $145.10M | Perrigo Company plc |
| Dividend Yield | N/A | 9.92% | N/A |
| 1-Year Return | 20.90% | -58.72% | Dynavax Technologies Corporation |
| Price-to-Sales Ratio (TTM) | 5.51 | 0.38 | Perrigo Company plc |
| Enterprise Value | $1.46B | $4.93B | Perrigo Company plc |
| EV/Revenue Ratio | 4.42 | 1.16 | Perrigo Company plc |
| Gross Profit Margin (TTM) | 84.82% | 32.64% | Dynavax Technologies Corporation |
| Revenue per Share (TTM) | $3 | $31 | Perrigo Company plc |
| Earnings per Share (Diluted) | $-0.37 | $-10.12 | Dynavax Technologies Corporation |
| Beta (Stock Volatility) | 0.93 | 0.49 | Perrigo Company plc |
| Short % of Float | 13.19% | 18.67% | Dynavax Technologies Corporation |
Dynavax Technologies Corporation vs Perrigo Company plc Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Dynavax Technologies Corporation | 0.00% | 0.13% | -1.15% | 40.40% | 47.90% | 0.78% |
| Perrigo Company plc | 0.00% | -3.15% | -8.17% | -15.24% | -23.14% | -24.69% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Dynavax Technologies Corporation | 20.90% | 39.64% | 53.92% | -21.40% | -49.68% | -74.59% |
| Perrigo Company plc | -58.72% | -66.51% | -76.52% | -88.64% | -86.89% | -34.38% |
Performance & Financial Health Analysis: Dynavax Technologies Corporation vs Perrigo Company plc
| Metric | DVAX | PRGO |
|---|---|---|
| Market Information | ||
| Market Cap | $1.82B | $1.61B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,683,447 | 2,169,621 |
| 90 Day Avg. Volume | 3,501,319 | 3,503,450 |
| Last Close | $15.50 | $10.46 |
| 52 Week Range | $9.20 - $15.73 | $9.23 - $28.44 |
| % from 52W High | -1.46% | -63.22% |
| All-Time High | $106.60 (Nov 27, 2006) | $215.73 (Apr 06, 2015) |
| % from All-Time High | -85.46% | -95.15% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.18% | -0.03% |
| Quarterly Earnings Growth | 0.53% | -0.03% |
| Financial Health | ||
| Profit Margin (TTM) | -0.13% | -0.34% |
| Operating Margin (TTM) | 0.25% | 0.10% |
| Return on Equity (TTM) | -0.07% | -0.39% |
| Debt to Equity (MRQ) | 54.15 | 131.16 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $4.55 | $21.33 |
| Cash per Share (MRQ) | $5.52 | $3.86 |
| Operating Cash Flow (TTM) | $90.63M | $238.50M |
| Levered Free Cash Flow (TTM) | $51.30M | $28.33M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 9.92% |
| Last 12-Month Dividend | N/A | $1.16 |
Valuation & Enterprise Metrics Analysis: Dynavax Technologies Corporation vs Perrigo Company plc
| Metric | DVAX (Feb 27, 2026) | PRGO (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 54.60 | 2,818.00 |
| Forward P/E | 46.97 | 4.93 |
| PEG Ratio | 0.71 | 0.91 |
| Price to Sales (TTM) | 5.51 | 0.38 |
| Price to Book (MRQ) | 3.41 | 0.55 |
| Market Capitalization | ||
| Market Capitalization | $1.82B | $1.61B |
| Enterprise Value | $1.46B | $4.93B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.42 | 1.16 |
| Enterprise to EBITDA | 60.37 | 7.26 |
| Risk & Other Metrics | ||
| Beta | 0.93 | 0.49 |
| Book Value per Share (MRQ) | $4.55 | $21.33 |
Financial Statements Comparison: Dynavax Technologies Corporation vs Perrigo Company plc
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | DVAX (2024) | PRGO (2025) |
|---|---|---|
| Revenue/Sales | 277.25M | 4.25B |
| Cost of Goods Sold | 49.45M | 2.76B |
| COGS % of Revenue | 17.8% | 64.9% |
| Gross Profit | 227.80M | 1.49B |
| Gross Margin | 82.2% | 35.1% |
| Research & Development | 61.55M | 95.40M |
| Operating Income (EBIT) | -4.12M | 312.80M |
| Operating Margin | -1.5% | 7.4% |
| EBITDA | 45.70M | 637.10M |
| EBITDA Margin | 16.5% | 15.0% |
| Pre-Tax Income | 30.86M | -1.30B |
| Pre-Tax Income % of Revenue | 11.1% | -30.5% |
| Income Tax | 3.55M | 104.40M |
| Income Tax % of Revenue | 1.3% | 2.5% |
| Net Income (Profit) | 27.31M | -1.43B |
| Profit Margin | 9.9% | -33.5% |
Balance Sheet & Liquidity Metrics
| Metric | DVAX (2024) | PRGO (2025) |
|---|---|---|
| Cash & Equivalents | 95.88M | 531.60M |
| Total Current Assets | 848.94M | 2.80B |
| Total Current Assets % of Revenue | 306.2% | 65.8% |
| Total Current Liabilities | 78.63M | 1.01B |
| Total Current Liabilities % of Revenue | 28.4% | 23.8% |
| Long-Term Debt | 250.24M | 3.60B |
| Long-Term Debt % of Revenue | 90.3% | 84.7% |
| Total Shareholders Equity | 596.80M | 2.94B |
| Retained Earnings | -903.28M | -3.68B |
| Retained Earnings % of Revenue | -325.8% | -86.5% |
| Property, Plant & Equipment | 39.76M | 167.80M |
Cash Flow Statement Comparison
| Metric | DVAX (2024) | PRGO (2025) |
|---|---|---|
| Operating Cash Flow | 69.99M | -1.06B |
| Operating Cash Flow % of Revenue | 25.2% | -24.9% |
| Capital Expenditures | -6.35M | -93.40M |
| Free Cash Flow | 60.16M | 145.10M |
| FCF Margin | 21.7% | 3.4% |
| Debt Repayment | N/A | -34.80M |
| Common Stock Repurchase | -100.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DVAX | PRGO |
|---|---|---|
| Shares Short | 9.79M | 16.69M |
| Short Ratio | 2.81 | 3.99 |
| Short % of Float | 13.19% | 18.67% |
| Shares Outstanding | 117.36M | 137.62M |
| Float Shares | 100.34M | 136.81M |
| % Held by Insiders | 0.75% | 0.41% |
| % Held by Institutions | 101.55% | 115.48% |
| % Held by Public | -2.30% | -15.89% |
Dividend Analysis & Yield Comparison: Dynavax Technologies Corporation vs Perrigo Company plc
| Metric | DVAX | PRGO |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.16 |
| Last 12-Month Dividend Yield | N/A | 9.92% |
| 3-Year Avg Annual Dividend | N/A | $1.12 |
| 3-Year Avg Dividend Yield | N/A | 1.09% |
| 3-Year Total Dividends | N/A | $3.36 |
| Ex-Dividend Date | N/A | Mar 02, 2026 |